How to buy DarioHealth stock (DRIO)

DarioHealth is a health information services business based in the US. DarioHealth shares (DRIO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.74 – an increase of 1.13% over the previous week. DarioHealth employs 276 staff and has a trailing 12-month revenue of around $23.1 million.

Our top picks for where to buy DarioHealth stock

Buy DarioHealth stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

DarioHealth stock price (NASDAQ: DRIO)

Use our graph to track the performance of DRIO stocks over time.

DarioHealth shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$0.74
52-week range	$0.65 - $2.60
50-day moving average more info button	$0.87
200-day moving average more info button	$1.16
Wall St. target price	$3.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.93

Is it a good time to buy DarioHealth stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DarioHealth price performance over time

Historical closes compared with the close of $0.65 from 2024-12-18

1 week (2024-12-12)	-13.33%
1 month (2024-11-20)	-16.67%
3 months (2024-09-19)	-34.99%
6 months (2024-06-18)	-40.91%

1 year (2023-12-19)	-61.31%
2 years (2022-12-19)	-83.91%
3 years (2021-12-17)	13.49
5 years (2019-12-19)	6.05

DarioHealth financials

Revenue TTM	$23.1 million
Gross profit TTM	$14 million
Return on assets TTM	-34.74%
Return on equity TTM	-74.91%
Profit margin	-205.62%
Book value	$1.87
Market Capitalization more info button	$22.2 million

TTM: trailing 12 months

DarioHealth share dividends

We're not expecting DarioHealth to pay a dividend over the next 12 months.

Have DarioHealth's shares ever split?

DarioHealth's shares were split on a 1:20 basis on 17 November 2019 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DarioHealth shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for DarioHealth shares which in turn could have impacted DarioHealth's share price.

DarioHealth share price volatility

Over the last 12 months, DarioHealth's shares have ranged in value from as little as $0.65 up to $2.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DarioHealth's is 1.511. This would suggest that DarioHealth's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

DarioHealth overview

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp.

Frequently asked questions

null
What percentage of DarioHealth is owned by insiders or institutions?
Currently 22.902% of DarioHealth shares are held by insiders and 23.571% by institutions. How many people work for DarioHealth?
Latest data suggests 276 work at DarioHealth. When does the fiscal year end for DarioHealth?
DarioHealth's fiscal year ends in December. Where is DarioHealth based?
DarioHealth's address is: 122 W 57th St,, New York, NY, United States, 10019 What is DarioHealth's ISIN number?
DarioHealth's international securities identification number is: US23725P2092 What is DarioHealth's CUSIP number?
DarioHealth's Committee on Uniform Securities Identification Procedures number is: 23725P209